US2008234222A1PendingUtilityA1

Charge Reversal of Polyion Complexes

68
Assignee: WOLFF JON APriority: Jul 17, 1998Filed: Jun 3, 2008Published: Sep 25, 2008
Est. expiryJul 17, 2018(expired)· nominal 20-yr term from priority
A61K 48/00A61K 47/59A61K 47/58C12N 15/87A61K 47/645A61K 47/60
68
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

An ionic polymer is utilized in “recharging” (another layer having a different charge) a condensed polynucleotide complex for purposes of nucleic acid delivery to a cell. The resulting recharged complex can be formed with an appropriate amount of positive or negative charge such that the resulting complex has the desired net charge.

Claims

exact text as granted — not AI-modified
1  A process for delivering a nucleic acid to a cell in vivo, comprising:
 a) forming a composition consisting of a nucleic acid associated via a non-covalent ionic interaction with a polycation in a solution wherein the composition has a net charge less negative than the nucleic acid;   b) ionically associating a polyanion with the composition of step a) in sufficient amount to form a complex having a net negative charge;   c) inserting the complex into a mammal;   d) delivering the complex to the cell.   
     
     
         2 . The process of  claim 1  wherein the polycation is selected from the group consisting of polylysine and polyethylenimine. 
     
     
         3 . The process of  claim 1  wherein the polyanion comprises a molecule selected from the group consisting of succinylated PLL, succinylated PEI, polyglutamic acid, polyaspartic acid, polyacrylic acid, polymethacrylic acid, dextran sulfate, heparin, hyaluronic acid, DNA, RNA, and negatively charged proteins. 
     
     
         4 . The process of  claim 1  wherein the polyanion comprises a block co-polymer. 
     
     
         5 . The process of  claim 1  wherein the polyanion comprises a molecule selected from the group consisting of pegylated derivatives, pegylated derivatives carrying specific ligands, block copolymers, graft copolymers and hydrophilic polymers.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.